They found these types of macrophages to improve prognosis in patients with triple-negative breast cancer (TNBC); moreover, CD206+ expression in macrophages was associated with smaller tumor size and higher TILs levels [36]. Here, MRC1 is linked to triple-negative breast carcinoma.